Title:Clinical Pharmacists’ Contribution to Medication Reconciliation in Outpatient
Specialty Clinics in Iran
Volume: 17
Issue: 3
Author(s): Maryam Mehrpooya, Mohammad-Reza Khorami, Mojdeh Mohammadi, Younes Mohammadi and Davoud Ahmadimoghaddam*
Affiliation:
- Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan,
Iran
Keywords:
Medication reconciliation, medication discrepancy, outpatient setting, medication error, medication safety, patient safety, clinical pharmacist.
Abstract:
Background: The majority of research in medication reconciliation has focused on the
inpatient settings, and little is known about the outpatient settings, particularly in developing countries.
As such, we conducted this study to evaluate direct clinical pharmacist involvement in medication
reconciliation in outpatient specialty clinics in Iran.
Methods: This prospective interventional study was conducted from September 2019 to February
2020 in a University-affiliated clinic in Iran. For 196 patients over 18 years of age who were scheduled
for an appointment with a physician, medication reconciliation intervention was carried out by
a clinical pharmacist. The number and type of unintentional discrepancies, their potential harm to
the patients, their correlation with the patients' demographic and clinical characteristics, and the
number of accepted recommendations upon the unintentional discrepancies by the clinicians were
assessed and recorded. Additionally, patients' understanding of any change made to their current
medication regimen was also assessed.
Results: In total, 57.14% of patients had at least one or more unintentional medication discrepancies,
with an overall rate of 1.51 (±0.62) per patient. This is while the patient understanding of their
medication changes was inadequate in a significant proportion of the study patients (62.2%). Patients
with older ages, lower educational levels, and a higher number of medications and comorbidities
were at a higher risk of having unintentional discrepancies. The most common type of unintentional
discrepancy was the omission of a drug, and almost half of the reconciliation errors might
have had the potential to cause moderate or severe harm to the patient. From 145 recommendations
suggested by the clinical pharmacist upon unintentional discrepancies, 131 cases (90.34%) were accepted
and implemented by the clinicians.
Conclusion: These findings further support the need for conducting medication reconciliation in
outpatient settings to identify discrepancies and enhance the safety of patient medication use.
